PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$66.59
-2.38 (-3.45%)
As of Nov 5, 8:00 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 2 10%
Sell 1 5%
Price Target
Analyst Price Target +17.1% upside
Low Target $54.55
Average Target $77.98
High Target $125.35
Current Price $66.59
Current
$66.59
Target
$77.98
$54.55 $77.98 avg $125.35
Scenario Analysis
Bear Case
$54.55
-18.1%
Low target
Base Case
$77.98
+17.1%
Avg target
Bull Case
$125.35
+88.2%
High target
Risk/Reward
4.9x
Highly favorable
Price in Context
52-Week High
$90.87
-26.7% from high
52-Week Low
$58.80
+13.2% from low
50-Day SMA
$65.03
+2.4% vs SMA
200-Day SMA
$70.56
-5.6% vs SMA
RSI (14)
65.4
Neutral
Target vs 52W High
$77.98
-14.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%